Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Yara T E Lechanteur"'
Autor:
Nicole T M Saksens, Yara T E Lechanteur, Sanne K Verbakel, Joannes M M Groenewoud, Mohamed R Daha, Tina Schick, Sascha Fauser, Camiel J F Boon, Carel B Hoyng, Anneke I den Hollander
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0144367 (2016)
AIMS:Age-related macular degeneration (AMD) is a multifactorial disease, in which complement-mediated inflammation plays a pivotal role. A positive family history is an important risk factor for developing AMD. Certain lifestyle factors are shown to
Externí odkaz:
https://doaj.org/article/681377ea3c0344ab94094b180f2130fb
Autor:
Dzenita Smailhodzic, Freekje van Asten, Anna M Blom, Frida C Mohlin, Anneke I den Hollander, Johannes P H van de Ven, Ramon A C van Huet, Joannes M M Groenewoud, Yuan Tian, Tos T J M Berendschot, Yara T E Lechanteur, Sascha Fauser, Chris de Bruijn, Mohamed R Daha, Gert Jan van der Wilt, Carel B Hoyng, B Jeroen Klevering
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e112682 (2014)
UnlabelledAge-related macular degeneration (AMD) is the leading cause of blindness in the Western world. AMD is a multifactorial disorder but complement-mediated inflammation at the level of the retina plays a pivotal role. Oral zinc supplementation
Externí odkaz:
https://doaj.org/article/e0071239818d40fb8f9a03a69f7715c0
Autor:
Anita de Breuk, Yara T. E. Lechanteur, Galuh Astuti, Jordi Corominas Galbany, Caroline C. W. Klaver, Carel B. Hoyng, Anneke I. den Hollander
Publikováno v:
Clinical Genetics, 102, 414-423
Clinical Genetics, 102(5), 414-423. Wiley-Blackwell Publishing Ltd
Clinical Genetics, 102, 5, pp. 414-423
Clinical Genetics, 102(5), 414-423. Wiley-Blackwell Publishing Ltd
Clinical Genetics, 102, 5, pp. 414-423
Contains fulltext : 288257.pdf (Publisher’s version ) (Open Access) Early onset drusen maculopathy (EODM) can lead to advanced macular degeneration at a young age, affecting quality of life. However, the genetic causes of EODM are not well studied.
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 166
Age-related macular degeneration (AMD) is a highly prevalent retinal disease in the elderly with a potential deleterious effect on quality of life. Since the introduction of intra-ocular anti-vascular endothelial growth factor (anti-VEGF) injections,
Autor:
Anneke I. den Hollander, Laura Lorés-Motta, Yara T. E. Lechanteur, Carel B. Hoyng, Thomas J. Heesterbeek
Publikováno v:
Ophthalmic & Physiological Optics
Ophthalmic and physiological optics, 40, 2, pp. 140-170
Ophthalmic and physiological optics, 40, 140-170
Ophthalmic and physiological optics, 40, 2, pp. 140-170
Ophthalmic and physiological optics, 40, 140-170
Contains fulltext : 219118.pdf (Publisher’s version ) (Open Access) PURPOSE: Age-related macular degeneration (AMD) is a degenerative disease of the macula, often leading to progressive vision loss. The rate of disease progression can vary among in
Autor:
Sarah de Jong, Carel B. Hoyng, Lambert P J W van den Heuvel, Anita de Breuk, Elena B. Volokhina, Yara T. E. Lechanteur, Alejandro Garanto, Sascha Fauser, Suresh Katti, Bjorn Bakker, Anneke I. den Hollander
Publikováno v:
Human Molecular Genetics, 31, 455-70
Human Molecular Genetics, 31, 3, pp. 455-70
Human Molecular Genetics, 31, 3, pp. 455-70
Age-related macular degeneration (AMD) is a major cause of vision loss among the elderly in the Western world. Genetic variants in the complement factor H (CFH) gene are associated with AMD, but the functional consequences of many of these variants a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f32a9ecf69385e49c5e9c94afcf04f0
http://hdl.handle.net/2066/248812
http://hdl.handle.net/2066/248812
Autor:
Cláudia Farinha, Patrícia Barreto, Rita Coimbra, Adela Iutis, Maria Luz Cachulo, José Cunha-Vaz, Yara T. E. Lechanteur, Carel B. Hoyng, Rufino Silva
Publikováno v:
Investigative Ophthalmology and Visual Science, 63
Investigative Ophthalmology and Visual Science, 63, 9
Investigative Ophthalmology and Visual Science, 63, 9
To determine the association between rare genetic variants in complement factor H (CFH) and phenotypic features in age-related macular degeneration (AMD) patients from the Coimbra Eye Study (CES).AMD patients from the Incidence CES (NCT02748824) unde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcb27216a5c8a387e13c0707c4164da6
http://hdl.handle.net/2066/253340
http://hdl.handle.net/2066/253340
Autor:
Anita de Breuk, Sarah de Jong, Lambert P J W van den Heuvel, Yara T. E. Lechanteur, Anneke I. den Hollander, Giuliana Gagliardi, Suresh Katti, Alejandro Garanto, Elena B. Volokhina
Publikováno v:
Progress in Retinal and Eye Research, 84
Contains fulltext : 237835.pdf (Publisher’s version ) (Open Access) Age-related macular degeneration (AMD) is the main cause of vision loss among the elderly in the Western world. While AMD is a multifactorial disease, the complement system was ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15f9d6315a94c3fde9720e41de5bac6d
Autor:
Carel B. Hoyng, Jenneke J. Keizer-Garritsen, Else Kragt, Alain J. van Gool, Sascha Fauser, Jolein Gloerich, Marien I. de Jonge, Elod Koertvely, Tessel E. Galesloot, Yara T. E. Lechanteur, I. Erkin Acar, Bjorn Bakker, Anneke I. den Hollander, Esther Willems, Eveline Kersten, Laura Lorés-Motta, Everson Nogoceke
Publikováno v:
Journal of Personalized Medicine, 11
Journal of Personalized Medicine
Journal of Personalized Medicine, 11, 12
Journal of Personalized Medicine, Vol 11, Iss 1256, p 1256 (2021)
Journal of Personalized Medicine; Volume 11; Issue 12; Pages: 1256
Journal of Personalized Medicine
Journal of Personalized Medicine, 11, 12
Journal of Personalized Medicine, Vol 11, Iss 1256, p 1256 (2021)
Journal of Personalized Medicine; Volume 11; Issue 12; Pages: 1256
Contains fulltext : 244088.pdf (Publisher’s version ) (Open Access) Age-related macular degeneration (AMD) is a major cause of vision loss among the elderly in the Western world. The complement system has been identified as one of the main AMD dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60ecb3292ddeff4d72548ab52d4f25ad
http://hdl.handle.net/2066/244088
http://hdl.handle.net/2066/244088
Autor:
Dzenita Smailhodzic, B. Jeroen Klevering, Tina Schick, Thomas J. Heesterbeek, Mohamed R. Daha, Yara T. E. Lechanteur, Sandra Liakopoulos, Lebriz Altay, Carel B. Hoyng, Laura Lorés-Motta, Eiko K. de Jong, Anneke I. den Hollander
Publikováno v:
Investigative Ophthalmology and Visual Science, 61
7th International Symposium on AMD: Age-related Macular Degeneration-Understanding Pathogenetic Mechanisms of Disease; 20190920-20190921; Baden-Baden; DOC19amd15 /20200205/
Investigative Ophthalmology and Visual Science, 61, 3
Investigative Ophthalmology & Visual Science
Investigative Ophthalmology & Visual Science, 61(3). ASSOC RESEARCH VISION OPHTHALMOLOGY INC
7th International Symposium on AMD: Age-related Macular Degeneration-Understanding Pathogenetic Mechanisms of Disease; 20190920-20190921; Baden-Baden; DOC19amd15 /20200205/
Investigative Ophthalmology and Visual Science, 61, 3
Investigative Ophthalmology & Visual Science
Investigative Ophthalmology & Visual Science, 61(3). ASSOC RESEARCH VISION OPHTHALMOLOGY INC
Background: To study the levels of complement activation in different disease stages of age-related macular degeneration (AMD) and the influence of genetic polymorphisms in complement genes. Methods: We included 797 AMD patients and 945 controls from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::233cf908324edab45c5fae68caee3628
https://hdl.handle.net/1887/3185008
https://hdl.handle.net/1887/3185008